Canadian urological association

Federal government websites often end in. The site is secure.

McMaster Institute of Urology at St. Published: Robotic-assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction A retrospective review of a high-volume Canadian center Michael Ordon, Aren Mnatzakanian, Melody Djuimo, R. Vangala, Mohammed Bassuony, Ahmed S. Zakaria, Walid Shahrour, Hazem Elmansy. High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience Hanbo Zhang, Nimira S.

Canadian urological association

Federal government websites often end in. The site is secure. As we exited the pandemic, healthcare within Canada was forced to take stock of the unmet clinical care needs and assign priorities to address those demands. In order to best assist our members and their patients as we faced the post-pandemic new world order, CUA leadership felt it important to obtain the most updated information on the current state of urology in Canada. To that end, a census was developed and circulated to the CUA membership. The intention was to collect data on membership demographics and practice patterns, as well as to better understand workforce and resource challenges across the country. Moreover, it was hoped that the information obtained could be used by the CUA in its advocacy efforts with licensing, accrediting bodies, and policymakers. Demographic surveys of the CUA membership had previously been conducted in and , focusing primarily on workforce issues. It was felt a more comprehensive sampling was needed to better understand contemporary demographics and practice patterns. A request for proposal RFP process was initiated in January by the CUA in order to identify a Canadian media organization capable of partnering with us to fulfill the requirements of the proposed survey. It was emphasized that in addition to obtaining information on the current state of urology in Canada, the long-term intention was to collect longitudinal data over time in order to identify trends and monitor the impact of the administration of health policy changes.

Justification: Although the frequency at which PSA screening should be performed has not been rigorously studied to date, canadian urological association, canadian urological association can extrapolate from the existing clinical trials and observational studies to provide some guidance on this issue. Moreover, it was hoped that the information obtained could be used by the CUA in its advocacy efforts with licensing, accrediting bodies, and policymakers.

The Canadian Urological Association CUA does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website. For comments or information, email Corporate.

The Canadian Urological Association CUA does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website. For comments or information, email Corporate. Privacy Policy. Upcoming Events. Canadian Urological Association Journal. Patient Information and Brochures. Subscribe to.

Canadian urological association

Federal government websites often end in. The site is secure. Preview improvements coming to the PMC website in October Learn More or Try it out now. Prostate cancer remains the most commonly diagnosed non-cutaneous malignancy among Canadian men and is the third leading cause of cancer-related death. In , an estimated 21 men were diagnosed with prostate cancer and men died from the disease; 1 however, prostate cancer is a heterogeneous disease with a clinical course ranging from indolent to life-threatening. Identifying and treating men with clinically significant prostate cancer while avoiding the over-diagnosis and over-treatment of indolent disease remains a significant challenge. Several professional associations have developed guidelines on prostate cancer screening and early diagnosis, but there are conflicting recommendations on how best to approach these issues. With recent updates from several large, randomized, prospective trials, as well as the emergence of several new diagnostic tests, the Canadian Urological Association CUA has developed these evidence-based recommendations to guide clinicians on prostate cancer screening and early diagnosis for Canadian men. The aim of these recommendations is to provide guidance on the current best prostate cancer screening and early diagnosis practices and to provide information on new and emerging diagnostic modalities.

New oriental dumfries

Br J Cancer. Pathological and clinical findings to predict tumor extent of nonpalpable stage T1c prostate cancer. There have been six randomized, controlled trials investigating the role of PSA screening in adult men; 9 — 14 however, three of these studies are at significant risk of bias and are generally not considered when weighing the evidence for or against prostate cancer screening. Participants were asked whether their practices were currently hiring or expecting to hire additional urologists within the next five years. Financial situation was mentioned as the main factor that might delay their decision. Prostate-specific antigen screening in the United States vs. Supplementary Information Supplementary Table 1 Prostate cancer screening guidelines by other organizations. Strategy for detection of prostate cancer based on relation between prostate-specific antigen at age 40 — 55 and long-term risk of metastasis: Case-control study. Alimohamed, Naveen S. Figure 2. We hope that these recommendations will help promote initiatives for improving the health of Canadian men. Saunders, Christopher C. Ross J. Decline in prostate cancer mortality from to , and an update on incidence trends in Olmsted County, Minnesota. Census surveys rely on individuals self-reporting and, therefore, the responses cannot be validated and are potentially subject to bias.

Federal government websites often end in. The site is secure.

Apr 28, Workforce needs and resource access challenges are topics of importance to the Health Policy and the newly created Advocacy Committees; the data collected can be shared with policymakers to bring forward, in concrete terms, the issues facing Canadian urologists and their patients. Justification: Prostate cancer screening is one of the most controversial issues in urology and preventative medicine. Preventive Services Task Force recommendations against prostate-specific antigen screening on prostate biopsy and cancer detection rates. Variation of serum prostate-specific antigen levels: An evaluation of year-to-year fluctuations. For biopsy-naive patients at elevated risk of clinically significant prostate cancer csPCa , mpMRI is recommended prior to biopsy in patients who are candidates for curative management with suspected clinically localized prostate cancer. Weighting was applied based on the CUA membership by province in order to render a representative sample from all regions. National Comprehensive Cancer Network. Prostate-specific antigen screening in the United States vs. Reducing the harm of prostate cancer screening: Repeated prostate-specific antigen testing. Participants practicing in Quebec and the Prairie provinces reported higher rates of difficulty than other regions. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. At the time the survey was conducted, there were active and senior members still practicing. The CUA is grateful to all members who participated and who shared their experiences. Consider referral for biopsy if DRE is very suspicious.